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lthough the concept of 
“bone quality” is at least 15 
years old [1], the term has 
recently sparked much discussion and 
debate among clinicians and clinical 
researchers [2–5]. At a recent National 
Institutes of Health conference on 
bone quality, the term was deﬁ  ned as: 
“The sum total of characteristics of the 
bone that inﬂ  uence the bone’s resistance to 
fracture” [6]. 
Where Did the Deﬁ  nition 
Come From?
This deﬁ  nition arose from the results 
of multicenter clinical trials that 
evaluated the effects of two classes of 
drugs—antiresorptive bisphosphonate 
therapy (alendronate and risedronate) 
and selective estrogen receptor 
modulator therapy (raloxifene)—on 
the prevention of osteoporotic fragility 
fractures [7,8]. While these studies 
reported consistent reductions in the 
incidence of fractures, the treatment 
effects could not be explained by 
contemporary changes in dual X-ray 
absorptiometric bone mineral density 
(BMD), the present clinical standard 
of bone fragility. These conﬂ  icting 
ﬁ  ndings led to speculation that the 
antiresorptive drugs had additional 
skeletal effects upon a feature of the 
bone called “bone quality” [7–12]. 
The idea of bone quality, and the 
explanation for the conﬂ  icting results, 
linked together two important notions: 
(1) antiresorptive drugs acted by 
suppressing bone turnover through 
inhibiting bone resorption, and (2) 
increased bone turnover (mainly the 
increased bone resorption, as detected 
by bone markers) compromises the 
bone strength through deteriorated 
bone microarchitecture (a trait 
that cannot be captured by BMD 
measurement but could potentially 
be improved by antiresorptive 
treatment) [4]. 
Bone quality is now a widely 
embraced concept that seems to offer 
a solution to the classic paradox of 
osteoporosis: while low BMD values 
are associated with increased relative 
risk of fracture at the population 
level, the predictive value of BMD in 
an individual patient remains quite 
marginal [13–15]. And to further 
support the concept of bone quality, 
inclusion of increased bone turnover 
in fracture-predicting models has 
somewhat improved the ability to 
predict fracture risk independently of 
BMD [8,16–19]. 
Flaws in the Concept
Although the concept of bone quality 
might seem attractive for all of the 
reasons discussed above, nevertheless 
the notion has three major conceptual 
ﬂ  aws. 
BMD and bone quality do not 
explain fractures. First, although BMD 
indeed shows a strong correlation with 
whole bone strength in the laboratory 
setting (r up to ~0.9) [20], in the 
clinical setting, paradoxically, the 
overall proportion of various fragility 
fractures attributable to low BMD 
(indicating reduced bone strength) 
remains modest (from 0% to 44%) 
[15]. In other words, when looking at 
all types of fractures combined, over 
half occur among people who cannot 
be classiﬁ  ed as having osteoporosis 
in the sense of the World Health 
Organization’s operational deﬁ  nition 
of osteoporosis (BMD 2.5 standard 
deviations or more below the young 
adult reference level). In fact, BMD is 
only a modest risk factor for fractures; 
about 85% of the contribution to 
the fracture risk in general, or to 
the rise in fracture risk with age, is 
unrelated to BMD [15,21]. In other 
words, the concept of bone quality is 
invoked to explain fracture risk that 
cannot be attributed to BMD, but it 
seems impossible that bone quality 
could realistically explain 85% of all 
fractures.
BMD and bone quality are largely 
inseparable. Second, the concept of 
bone quality rests on a commonly 
held idea that BMD and bone quality 
would independently account for bone 
fragility in totality. But this idea is a 
fallacy. Basically, BMD reﬂ  ects the 
bulk of material (bone mass) of which 
the bone, as an organ, is made [22]. 
BMD thus denotes a lumped measure 
of virtually everything within the 
measured bone site (i.e., bone cross-
sectional size and dimensions, cortical 
thickness and porosity, trabecular 
thickness and number, mineralization 
of bone material), but it denotes 
nothing speciﬁ  cally. Thus, there is 
not much left to be accounted for 
by subtle architectural and material 
properties (i.e., factors that allegedly 
account for bone quality). This simply 
means that BMD and most bone 
quality characteristics, measurable 
in vivo, are intertwined and largely 
inseparable. 
Flaws in deﬁ  ning bone quality. Third, 
the deﬁ  nition of bone quality is too 
imprecise, incorporating a pool of 
“non-BMD” indices of bone fragility 
(or, even more broadly, the portion 
of fracture risk that is not predicted 
by BMD [6]). Neither do we have an 
established measurement, indicator, or 
unit for bone quality. We don’t even 
have criteria for deﬁ  ning “good” or 
“bad” bone quality. 
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The Problem of Measurement
“If you can not measure it, you can 
not improve it.”
Lord Kelvin
In business and industry, quality is 
classically deﬁ  ned as “ﬁ  tness for use” 
[23] or “conformance to requirements” 
[24]. Extrapolating from these 
standard business deﬁ  nitions of quality, 
“good” bone quality would mean a 
high level of resistance to fractures, 
or extrapolating even further [6], 
resistance to all factors accounting 
for fracture risk. One might then ask 
whether the likelihood of a fracture 
is solely dependent on bone strength, 
and accordingly, whether a fracture 
that resulted from mild or moderate 
trauma is a direct index of “bad” bone 
quality. 
However, this kind of simplistic 
thinking ignores the fact that the 
etiology of any type of fracture 
among older adults is multifactorial, 
involving many extra-skeletal risk factors 
much stronger than the bone per se 
(measured by conventional BMD) [25–
33]. In this respect, one should recall 
that bone quality, by deﬁ  nition, cannot 
be but a bone-based trait only [2]. 
Even if the problems with the 
deﬁ  nition of bone quality could be 
solved, the fundamental problem with 
the bone quality concept is common 
to all new diagnostic tests [34]: the 
clinical value of a new diagnostic 
test depends on whether it improves 
patient outcomes beyond the outcome 
achieved with current diagnostic tests 
(here, the BMD and other well-known 
risk factors of fractures). As mentioned 
previously, it is true that highly 
increased bone turnover has been 
shown to improve the ability to predict 
some types of fractures independently 
of BMD [8,17,18]. However, so far we 
have little proof that the biochemical 
markers of bone turnover would be 
able to make a clinically relevant 
impact on the predictive ability of 
fracture independently of the well-known 
risk factors of fractures. 
For example, incorporating a single 
non-skeletal risk factor (gait speed) 
into the predictive equation along with 
BMD and bone markers was shown to 
clearly diminish the fracture predictive 
ability of bone markers [17]. Thus, it 
remains quite utopian to envision that 
a pure bone-derived measure (e.g., 
BMD complemented by bone quality) 
could ever cover all these extra-skeletal 
risk factors, too, and thus, predict solely 
the individual occurrence of fractures. 
The prevailing understanding 
of bone quality supposes that the 
primary property of bones is their 
capacity to resist fractures. But this is a 
misconception. The human skeleton is 
basically a locomotive apparatus, which 
is continually adapting to habitual 
loadings [35,36] and is particularly ﬁ  t 
for endurance activities [37]. Given 
the intrinsic locomotive function and 
the metabolic pressure to keep the 
skeleton light, there is a compromise 
between the bone’s actual, functionally 
adequate strength and the maximum 
attainable strength. Bone has a great 
capacity to become substantially 
stronger through appropriate 
structural adaptations whenever 
needed to cope with increased 
functional demands [36]. However, 
while the skeleton can be reasonably 
well adapted to customary, functional 
loadings (Figure 1A), it is deﬁ  nitely not 
adapted to unusual loadings caused 
by occasional falls (or by other similar 
trauma-related events) [38]. Under 
such circumstances weak bone regions 
can become unduly stressed, possibly 
beyond their load-bearing capacity, 
initiating a fracture (Figure 1C). Fully 
in line with this fact, the relative risk 
of hip fracture can rise to up to 30 
when the fall-induced impact directly 
hits the greater trochanter of the 
proximal femur [26,28,39]. It is thus 
doi:10.1371/journal.pmed.0040027.g001
Figure 1. Bone Fractures, Car Accidents, and Direction of Impact
Analogous to automobiles designed to run on their wheels, the human skeleton is adapted to 
bipedal gait and the resulting habitual locomotive loadings (Figure 1A). In terms of safety, the 
design of cars is optimized to keep the driver and passengers in the cockpit intact during collisions 
from the typical directions of impact, the front or rear (Figure 1B). However, a similar or even 
smaller force can cause profound damage to the cockpit if it comes from an atypical (unforeseen) 
direction (Figure 1C). Analogously, the capacity of the skeleton to resist fractures during accidents 
is generally good when the loading caused by a traumatic incident is a moderate magniﬁ  cation 
of the loading experienced during habitual activities (i.e., within the inherent safety margin of 
bone), except in some cases where the incident force exceeds the bones’ capacity to withstand the 
loading without structural failure (Figure 1B). In many cases of older adults’ fractures, however, the 
incident loading in terms of direction, rate, and magnitude is essentially different from the loading 
that bones are adapted to (Figure 1C). Such cases can be caused, for example, by careless lifting of 
a shopping bag with straight knees [42,48] or a sideways fall directly onto the hip [26,30].
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quite understandable that the external 
loads from these non-habitual incidents 
cause most (up to ~90%) hip and wrist 
fractures [26,30,39] and also account 
for at least half of vertebral fractures 
[40–42]. 
Conclusion
In the end, the only reasonable 
mechanism by which any bone-targeted 
medication reduces fractures is through 
increasing the whole bone strength 
(one way or another). Accordingly, if 
we were able to accurately determine 
whole bone strength of individuals 
on antiresorptive therapy, the alleged 
discrepancy underlying the concept 
of bone quality would not exist. As 
the whole bone strength provides the 
ultimate measure of true bone quality, 
the paradox of osteoporosis appears 
to simply stem from our inherent 
inability to determine directly the 
actual bone strength of an individual in 
vivo. However, this inability cannot be 
taken as a justiﬁ  cation to introduce an 
obscure and ill-deﬁ  ned concept such as 
bone quality. 
If it really must be used, the term 
bone quality should refer only to the 
capacity of bones to withstand a wide 
range of loading without breaking—
though we already have a proper term 
for such capacity, the whole bone 
strength. Therefore, we must strive 
to reliably estimate the whole bone 
strength in vivo. In this context, the 
new 3-dimensional imaging techniques 
of the actual bone structure and 
macroanatomy seem an interesting 
and promising option [43–47] that will 
hopefully help in solving the important 
clinical issue of bone fragility in the 
near future.  
Acknowledgments 
This study was supported by grants from 
the Medical Research Fund of Tampere 
University Hospital, the Research Council 
for Physical Education and Sports, Ministry 
of Education, and the AO Research Fund, 
Switzerland. The authors thank Dr. Jarkko 
Jokihaara for help with preparation of the 
ﬁ  gure. 
References
1.  Wallach S, Feinblatt JD, Carstens JH Jr, Avioli 
LV (1992) The bone “quality” problem. Calcif 
Tissue Int 51: 169–172.
2.  Hernandez CJ, Keaveny TM (2006) A 
biomechanical perspective on bone quality. 
Bone 39: 1173–1181.
3.  Kleerekoper M (2006) Osteoporosis prevention 
and therapy: Preserving and building strength 
through bone quality. Osteoporos Int 17: 
1707–1715.
4.  Seeman E, Delmas PD (2006) Bone quality—
The material and structural basis of bone 
strength and fragility. N Engl J Med 354: 2250–
2261.
5.  Stokstad E (2005) Bone quality ﬁ  lls holes in 
fracture risk. Science 308: 1580.
6.  Fyhrie DP (2005) Summary—Measuring “bone 
quality.” J Musculoskelet Neuronal Interact 5: 
318–320.
7.  Ettinger MP (2003) Aging bone and 
osteoporosis: Strategies for preventing fractures 
in the elderly. Arch Intern Med 163: 2237–
2246.
8.  Garnero P, Sornay-Rendu E, Claustrat B, 
Delmas PD (2000) Biochemical markers of 
bone turnover, endogenous hormones and the 
risk of fractures in postmenopausal women: 
The OFELY study. J Bone Miner Res 15: 1526–
1536.
9.  Faulkner KG (2000) Bone matters: Are density 
increases necessary to reduce fracture risk? J 
Bone Miner Res 15: 183–187.
10. Heaney RP (2003) Is the paradigm shifting? 
Bone 33: 457–465.
11. Melton LJ 3rd, Khosla S, Atkinson EJ, O’Fallon 
WM, Riggs BL (1997) Relationship of bone 
turnover to bone density and fractures. J Bone 
Miner Res 12: 1083–1091.
12. Riggs BL, Melton LJ 3rd (2002) Bone turnover 
matters: The raloxifene treatment paradox 
of dramatic decreases in vertebral fractures 
without commensurate increases in bone 
density. J Bone Miner Res 17: 11–14.
13. Sanders KM, Nicholson GC, Watts JJ, Pasco 
JA, Henry MJ, et al. (2006) Half the burden 
of fragility fractures in the community occur 
in women without osteoporosis. When is 
fracture prevention cost-effective? Bone 38: 
694–700.
14. Siris ES, Chen YT, Abbott TA, Barrett-Connor 
E, Miller PD, et al. (2004) Bone mineral density 
thresholds for pharmacological intervention 
to prevent fractures. Arch Intern Med 164: 
1108–1112.
15. Stone KL, Seeley DG, Lui LY, Cauley JA, 
Ensrud K, et al. (2003) BMD at multiple sites 
and risk of fracture of multiple types: Long-
term results from the Study of Osteoporotic 
Fractures. J Bone Miner Res 18: 1947–1954.
16. Garnero P, Delmas PD (2004) Contribution 
of bone mineral density and bone turnover 
markers to the estimation of risk of 
osteoporotic fracture in postmenopausal 
women. J Musculoskelet Neuronal Interact 4: 
50–63.
17. Garnero P, Hausherr E, Chapuy MC, Marcelli 
C, Grandjean H, et al. (1996) Markers of bone 
resorption predict hip fracture in elderly 
women: The EPIDOS Prospective Study. J Bone 
Miner Res 11: 1531–1538.
18. Gerdhem P, Ivaska KK, Alatalo SL, Halleen 
JM, Hellman J, et al. (2004) Biochemical 
markers of bone metabolism and prediction of 
fracture in elderly women. J Bone Miner Res 
19: 386–393.
19. Johnell O, Oden A, De Laet C, Garnero P, 
Delmas PD, et al. (2002) Biochemical indices of 
bone turnover and the assessment of fracture 
probability. Osteoporos Int 13: 523–526.
20. Bouxsein ML, Coan BS, Lee SC (1999) 
Prediction of the strength of the elderly 
proximal femur by bone mineral density and 
quantitative ultrasound measurements of the 
heel and tibia. Bone 25: 49–54.
21. Wilkin TJ, Devendra D (2001) Bone 
densitometry is not a good predictor of hip 
fracture. BMJ 323: 795–797.
22. Sievanen H (2000) A physical model for dual-
energy X-ray absorptiometry—Derived bone 
mineral density. Invest Radiol 35: 325–330.
23. Juran JM, Gryna FM (1974) Juran’s quality 
control handbook. Third edition. New York: 
Mcgraw-Hill.
24. Crosby PB (1979) Quality is free: The art of 
making quality certain. New York: Mcgraw-Hill.
25. Carter SE, Campbell EM, Sanson-Fisher 
RW, Gillespie WJ (2000) Accidents in older 
people living at home: A community-based 
study assessing prevalence, type, location and 
injuries. Aust N Z J Public Health 24: 633–636.
26. Hayes WC, Myers ER, Morris JN, Gerhart TN, 
Yett HS, et al. (1993) Impact near the hip 
dominates fracture risk in elderly nursing 
home residents who fall. Calcif Tissue Int 52: 
192–198.
27. Lee SH, Dargent-Molina P, Breart G (2002) 
Risk factors for fractures of the proximal 
humerus: Results from the EPIDOS prospective 
study. J Bone Miner Res 17: 817–825.
28. Nevitt MC, Cummings SR (1993) Type of 
fall and risk of hip and wrist fractures: The 
study of osteoporotic fractures. The Study of 
Osteoporotic Fractures Research Group. J Am 
Geriatr Soc 41: 1226–1234.
29. Palvanen M, Kannus P, Parkkari J, Pitkajarvi 
T, Pasanen M, et al. (2000) The injury 
mechanisms of osteoporotic upper extremity 
fractures among older adults: A controlled 
study of 287 consecutive patients and their 108 
controls. Osteoporos Int 11: 822–831.
30. Parkkari J, Kannus P, Palvanen M, Natri 
A, Vainio J, et al. (1999) Majority of hip 
fractures occur as a result of a fall and impact 
on the greater trochanter of the femur: A 
prospective controlled hip fracture study with 
206 consecutive patients. Calcif Tissue Int 65: 
183–187.
31. Robinovitch SN, Inkster L, Maurer J, Warnick 
B (2003) Strategies for avoiding hip impact 
during sideways falls. J Bone Miner Res 18: 
1267–1273.
32. Schwartz AV, Kelsey JL, Sidney S, Grisso JA 
(1998) Characteristics of falls and risk of hip 
fracture in elderly men. Osteoporos Int 8: 
240–246.
33. Wei TS, Hu CH, Wang SH, Hwang KL (2001) 
Fall characteristics, functional mobility and 
bone mineral density as risk factors of hip 
fracture in the community-dwelling ambulatory 
elderly. Osteoporos Int 12: 1050–1055.
34. Lord SJ, Irwig L, Simes RJ (2006) When is 
measuring sensitivity and speciﬁ  city sufﬁ  cient 
to evaluate a diagnostic test, and when do we 
need randomized trials? Ann Intern Med 144: 
850–855.
35. Frost HM (2003) Bone’s mechanostat: A 2003 
update. Anat Rec 275A: 1081–1101.
36. Ruff C, Holt B, Trinkaus E (2006) Who’s afraid 
of the big bad Wolff?: “Wolff’s law” and bone 
functional adaptation. Am J Phys Anthropol 
129: 484–498.
37. Bramble DM, Lieberman DE (2004) 
Endurance running and the evolution of 
Homo. Nature 432: 345–352.
38. Currey JD (2003) How well are bones designed 
to resist fracture? J Bone Miner Res 18: 
591–598.
39. Greenspan SL, Myers ER, Kiel DP, Parker RA, 
Hayes WC, et al. (1998) Fall direction, bone 
mineral density, and function: Risk factors for 
hip fracture in frail nursing home elderly. Am J 
Med 104: 539–545.
40. Cooper C, Atkinson EJ, Kotowicz M, O’Fallon 
WM, Melton LJ 3rd (1992) Secular trends in 
the incidence of postmenopausal vertebral 
fractures. Calcif Tissue Int 51: 100–104.
41. Cooper C, Atkinson EJ, O’Fallon WM, Melton 
LJ 3rd (1992) Incidence of clinically diagnosed 
vertebral fractures: A population-based study 
in Rochester, Minnesota, 1985–1989. J Bone 
Miner Res 7: 221–227.
42. Myers ER, Wilson SE (1997) Biomechanics of 
osteoporosis and vertebral fracture. Spine 22: 
25S–31S.
43. Carpenter RD, Beaupre GS, Lang TF, Orwoll 
ES, Carter DR (2005) New QCT analysis 
approach shows the importance of fall 
orientation on femoral neck strength. J Bone 
Miner Res 20: 1533–1542.
44. Cheng X, Li J, Lu Y, Keyak J, Lang T (2007) 
March 2007  |  Volume 4  |  Issue 3  |  e27PLoS Medicine  |  www.plosmedicine.org 0410
Proximal femoral density and geometry 
measurements by quantitative computed 
tomography: Association with hip fracture. 
Bone 40: 169–174.
45. Khosla S, Riggs BL, Atkinson EJ, Oberg AL, 
McDaniel LJ, et al. (2006) Effects of sex and 
age on bone microstructure at the ultradistal 
radius: A population-based noninvasive in vivo 
assessment. J Bone Miner Res 21: 124–131.
46. Lang T, Augat P, Majumdar S, Ouyang X, 
Genant HK (1998) Noninvasive assessment of 
bone density and structure using computed 
tomography and magnetic resonance. Bone 22: 
149S–153S.
47. Riggs BL, Melton LJ 3rd, Robb RA, Camp JJ, 
Atkinson EJ, et al. (2006) Population-based 
analysis of the relationship of whole bone 
strength indices and fall-related loads to 
age- and sex-speciﬁ  c patterns of hip and wrist 
fractures. J Bone Miner Res 21: 315–323.
48. Duan Y, Seeman E, Turner CH (2001) The 
biomechanical basis of vertebral body fragility 
in men and women. J Bone Miner Res 16: 
2276–2283.
March 2007  |  Volume 4  |  Issue 3  |  e27